Scientific publications

Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

Apr 1, 2018 | Magazine: Clinical & Translational Oncology

Garrido P (1), Aldaz A (2), Vera R (3), Calleja MA (4), de Álava E (5,6), Martín M (6,7), Matías-Guiu X (6,8), Palacios J (9,10).


Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.

Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system.

However, the implementation of precision medicine poses ethical-legal, regulatory, organizational, and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals, and jeopardizing the solvency of the healthcare system.

With this paper from the Spanish Societies of Medical Oncology, Pathology, and Hospital Pharmacy, we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.

CITATION  Clin Transl Oncol. 2018 Apr;20(4):443-447.  doi: 10.1007/s12094-017-1740-0.  Epub 2017 Aug 31.

Our authors